Adtalem Q2 revenue +8.4% to $393.2M, raises FY guidance; short seller report disclosed

Covista Inc.

2024-Q2 EPS reported $1.22 revenue$762,087,000

Revenue $393.2M (+8.4% YoY); total enrollment 81,772 (+6.2%); Chamberlain enrollment +6.6%, Walden +7.9%.
Diluted EPS $0.98; adjusted EPS $1.23 (+5.1% YoY); adjusted EBITDA $92.6M (+2.2%); margin 23.5%.
FY2024 guidance raised: revenue $1,520-$1,560M (from $1,470-$1,530M); adj. EPS $4.55-$4.75 (from $4.25-$4.45).
Completed $300M buyback; new $300M authorization through Jan 2027; repaid $50M Term Loan B; repriced $253M at 50bps lower; net leverage 1.5x.
Filed risk factor re: short seller report published Jan 30 alleging misconduct; share price impacted; may lead to litigation/regulatory probes.

item 2.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Covista Inc. reported second quarter fiscal 2024 (ended Dec. 31, 2023) results: revenue $393.2 million, net income $39.9 million, EPS $0.98 per diluted share. Guidance raised.

Period: second quarter fiscal 2024 (ended Dec. 31, 2023)
Revenue: $393.2 million
Net income: $39.9 million
EPS: $0.98 per diluted share
Guidance: raised
Result: reported results

Exact text from the filing

Guidance Raised Revenue up 8.4% YoY Total enrollment up 6.2% YoY Diluted earnings per share $0.98; Adjusted EPS $1.23, growth of 5.1% YoY Second quarter highlights ● Revenue $393.2 million, up 8.4% year-over-year ● Total student enrollment 81,772, up 6.2% year-over-year ● Chamberlain University fourth straight quarter of total enrollment growth, up 6.6%

View on SEC.gov

243 earnings releases filed in the last 30 days. Browse all earnings releases →

Covista Inc. filing history →

Source: SEC EDGAR

accession 0001157523-24-000136

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.